Catalyst Wire Dossier Catalyst Wire Dossier

Menstrual blood-derived cell therapy

menstrual blood-derived cell therapy · S-Evans Biosciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Menstrual blood-derived cell therapy, covering 2014-03-24 to 2014-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection [Phase 1, Phase 2]

See pricing